The Diagnostic Value of Combined 24-h BP and ECG Holter Monitoring in Detection of Cardiac Arrhythmias in Patients with Arterial Hypertension.

Arterial hypertension Cardiac arrhythmias combined 24-h BP and ECG Holter monitoring

Journal

Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH

ISSN: 0353-8109

Titre abrégé: Acta Inform Med

Pays: Bosnia and Herzegovina

ID NLM: 101147064

Informations de publication

Date de publication:
Mar 2022

Historique:

received: 03 02 2022

accepted: 20 03 2022

entrez: 8 7 2022

pubmed: 9 7 2022

medline: 9 7 2022

Statut: ppublish

Résumé

Arrhythmias are common problems in hypertensive patients. The presence and complexity of both supraventricular and ventricular arrhythmias may influence morbidity, mortality, as well as the quality of life of patients. The aim of this study was to assess the diagnostic value of combined 24h BP and ECG Holter monitoring in detection of cardiac arrhythmias in patients with arterial hypertension. We analyzed the simultaneous records of combined 24h BP and ECG Holter monitoring for 356 adult patients with diagnosed arterial hypertension in the period from January 2017 until January 2021 year. The cardiac arrhythmias were classified in three main groups as following: a) Supraventricular arrhythmias; b) Ventricular arrhythmias; c) Bradyarrhythmia's. Standard transthoracic echocardiograms were performed in order to evaluate signs of hypertensive or structural heart disease with focus on left ventricle hypertrophy and LV function. Patients had a mean age of 64 ± 11years, 62% male. Average clinic BP was 153.4+18/87.5+14 mmHg. More than 46% of patients displayed a very high-risk profile. In all enrolled patients, cardiac arrhythmia was detected in 302 (84%) patients. The total number of patients with supraventricular arrhythmias was 153 (50,7%). Ventricular arrhythmias were detected in 98 (32,5%) patients. Bradyarrhythmia's were detected in 51 (16,9%) patients. Elevated resting heart rate in sinus rhythm was detected in 87 (31,6%) of 275 patients with sinus rhythm. Most arrhythmias are related to longstanding arterial hypertension. Effective treatment of arterial hypertension plays important role in preventing structural and functional cardiac abnormalities which will contribute to the reduction of cardiac arrhythmias in hypertensive patients.

Sections du résumé

Background UNASSIGNED

Objective UNASSIGNED

The aim of this study was to assess the diagnostic value of combined 24h BP and ECG Holter monitoring in detection of cardiac arrhythmias in patients with arterial hypertension.

Methods UNASSIGNED

We analyzed the simultaneous records of combined 24h BP and ECG Holter monitoring for 356 adult patients with diagnosed arterial hypertension in the period from January 2017 until January 2021 year. The cardiac arrhythmias were classified in three main groups as following: a) Supraventricular arrhythmias; b) Ventricular arrhythmias; c) Bradyarrhythmia's. Standard transthoracic echocardiograms were performed in order to evaluate signs of hypertensive or structural heart disease with focus on left ventricle hypertrophy and LV function.

Results UNASSIGNED

Patients had a mean age of 64 ± 11years, 62% male. Average clinic BP was 153.4+18/87.5+14 mmHg. More than 46% of patients displayed a very high-risk profile. In all enrolled patients, cardiac arrhythmia was detected in 302 (84%) patients. The total number of patients with supraventricular arrhythmias was 153 (50,7%). Ventricular arrhythmias were detected in 98 (32,5%) patients. Bradyarrhythmia's were detected in 51 (16,9%) patients. Elevated resting heart rate in sinus rhythm was detected in 87 (31,6%) of 275 patients with sinus rhythm.

Conclusion UNASSIGNED

Most arrhythmias are related to longstanding arterial hypertension. Effective treatment of arterial hypertension plays important role in preventing structural and functional cardiac abnormalities which will contribute to the reduction of cardiac arrhythmias in hypertensive patients.

Identifiants

DOI: 10.5455/aim.2022.30.69-75 PMID: 35800905 PMC: PMC9226756

pubmed: 35800905

doi: 10.5455/aim.2022.30.69-75

pii: AIM-30-69

pmc: PMC9226756

doi:

Types de publication

Journal Article

Langues

eng

Pagination

69-75

Informations de copyright

Déclaration de conflit d'intérêts

None declared.

Références

Am J Cardiol. 2003 May 22;91(10A):9G-14G

pubmed: 12781903

Mater Sociomed. 2020 Mar;32(1):71-76

pubmed: 32410896

Am J Cardiol. 2014 Oct 1;114(7):1049-52

pubmed: 25118122

J Am Coll Cardiol. 2014 May 20;63(19):2007-13

pubmed: 24657688

Mater Sociomed. 2011;23(3):171-83

pubmed: 23922510

Am J Hypertens. 2001 Jul;14(7 Pt 1):637-43

pubmed: 11465647

Hypertens Res. 2007 Jun;30(6):535-40

pubmed: 17664857

Europace. 2017 Jun 1;19(6):891-911

pubmed: 28881872

Am J Cardiol. 2008 Jun 15;101(12):1792-5

pubmed: 18549861

Mater Sociomed. 2017 Dec;29(4):231-236

pubmed: 29284990

Eur Heart J. 2021 Feb 1;42(5):373-498

pubmed: 32860505

Hypertension. 2007 Mar;49(3):439-45

pubmed: 17224472

J Hum Hypertens. 2008 Jun;22(6):380-8

pubmed: 18337759

Eur Heart J. 2018 Sep 1;39(33):3021-3104

pubmed: 30165516

JAMA Netw Open. 2019 May 3;2(5):e194176

pubmed: 31125096

Europace. 2002 Apr;4(2):175-82

pubmed: 12135251

Am J Med. 2015 Mar;128(3):219-28

pubmed: 25447617

Med Arch. 2017 Oct;71(5):316-319

pubmed: 29284897

J Clin Hypertens (Greenwich). 2020 Aug;22(8):1371-1378

pubmed: 32772484

Hypertension. 2003 Feb;41(2):218-23

pubmed: 12574085

J Hum Hypertens. 2008 Jul;22(7):460-7

pubmed: 18432258

J Ayub Med Coll Abbottabad. 2010 Oct-Dec;22(4):155-8

pubmed: 22455286

Hypertension. 2018 Jun;71(6):1269-1324

pubmed: 29133354

JAMA Intern Med. 2018 Jan 1;178(1):28-36

pubmed: 29131895

Med Arch. 2016 Jul 27;70(4):274-279

pubmed: 27703288

Minerva Cardioangiol. 2000 Dec;48(12):427-34

pubmed: 11253327

Eur Heart J. 2008 May;29(10):1327-34

pubmed: 18375982

Int J Cardiol. 2018 Mar 1;254:136-141

pubmed: 29407080